Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)NB-001 in Children and Adolescents With 22q11 Deletion Syndrome
- First Posted Date
- 2022-03-22
- Last Posted Date
- 2025-02-10
- Lead Sponsor
- Nobias Therapeutics, Inc.
- Target Recruit Count
- 37
- Registration Number
- NCT05290493
- Locations
- 🇺🇸
Children's Hospital Colorado, Aurora, Colorado, United States
🇺🇸Children's Hospital of Philadelphia (CHOP), Philadelphia, Pennsylvania, United States
🇺🇸Seattle Children's Hospital, Seattle, Washington, United States
News
No news found